Enhanced production of nargenicin A1 and creation of a novel derivative using a synthetic biology platform.

scientific article published on 14 July 2016

Enhanced production of nargenicin A1 and creation of a novel derivative using a synthetic biology platform. is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1008217116
P356DOI10.1007/S00253-016-7705-3
P698PubMed publication ID27412463

P50authorDipesh DhakalQ57555503
Tokutaro YamaguchiQ61145386
Anaya Raj PokhrelQ89532099
Hye Jin JungQ92334205
Jae Kyung SohngQ57555493
P2093author name stringByung-Gee Kim
Prakash Parajuli
Anil Shrestha
Amit Kumar Chaudhary
Seung-Young Kim
Jeong Sang Yi
Biplav Shrestha
P2860cites workEnzymatic assembly of DNA molecules up to several hundred kilobasesQ28241142
Use of Dinitrosalicylic Acid Reagent for Determination of Reducing SugarQ29305147
Natural products as sources of new drugs over the 30 years from 1981 to 2010Q29616640
Plasmid cloning vectors for the conjugal transfer of DNA from Escherichia coli to Streptomyces spp.Q33227202
BglBricks: A flexible standard for biological part assemblyQ33657298
The re-emergence of natural products for drug discovery in the genomics era.Q34459318
Production, isolation and biological activity of nargenicin from Nocardia sp. CS682.Q34867855
Nargenicin enhances 1,25-dihydroxyvitamin D(3)- and all-trans retinoic acid-induced leukemia cell differentiation via PKCbetaI/MAPK pathwaysQ34980103
DNA assembler: a synthetic biology tool for characterizing and engineering natural product gene clustersQ35064599
Improvement of antibiotic activity of Xenorhabdus bovienii by medium optimization using response surface methodologyQ35582878
Commentary: Toward a new focus in antibiotic and drug discovery from the Streptomyces arsenalQ35856285
De novo biosynthetic pathways: rational design of microbial chemical factoriesQ37251461
Response surface methodology (RSM) as a tool for optimization in analytical chemistryQ37257532
Metabolic engineering of microorganisms: general strategies and drug productionQ37262445
Construction and optimization of synthetic pathways in metabolic engineeringQ37706740
Molecular insights on the biosynthesis of antitumour compounds by actinomycetesQ37845949
Synthetic biology and the development of tools for metabolic engineeringQ37982199
Elucidation of DnaE as the Antibacterial Target of the Natural Product, NargenicinQ38411940
Genetic Manipulation of Nocardia Species.Q38417455
Laboratory Maintenance of Nocardia Species.Q38420831
Herboxidiene biosynthesis, production, and structural modifications: prospect for hybrids with related polyketideQ38423236
Structural modification of herboxidiene by substrate-flexible cytochrome P450 and glycosyltransferase.Q38428716
Enhanced production of nargenicin A(1) and generation of novel glycosylated derivatives.Q38429805
Biosynthesis of the nargenicin A1 pyrrole moiety from Nocardia sp. CS682.Q38470350
Metabolic engineering of natural product biosynthesis in actinobacteriaQ38801966
Functional expression of the glucose transporter of Zymomonas mobilis leads to restoration of glucose and fructose uptake in Escherichia coli mutants and provides evidence for its facilitator actionQ39837166
Nargenicin attenuates lipopolysaccharide-induced inflammatory responses in BV-2 cellsQ39846327
Engineering yield and rate of reductive biotransformation in Escherichia coli by partial cyclization of the pentose phosphate pathway and PTS-independent glucose transport.Q40961968
Successive nonstatistical and statistical approaches for the improved antibiotic activity of rare actinomycete Nonomuraea sp. JAJ18.Q41808946
An insight into the "-omics" based engineering of streptomycetes for secondary metabolite overproductionQ42181821
Re-engineering of genetic circuit for 2-deoxystreptamine (2-DOS) biosynthesis in Escherichia coli BL21 (DE3).Q43498892
Phosphoenolpyruvate availability and the biosynthesis of shikimic acidQ44468174
Biosynthesis of pyrrolylpolyenes in Auxarthron umbrinum.Q46198902
Enhancement of UDPG synthetic pathway improves ansamitocin production in Actinosynnem pretiosum.Q50910710
Analysis of intracellular short organic acid-coenzyme A esters from actinomycetes using liquid chromatography-electrospray ionization-mass spectrometry.Q53568509
ePathBrick: a synthetic biology platform for engineering metabolic pathways in E. coli.Q54311805
P433issue23
P407language of work or nameEnglishQ1860
P921main subjectsynthetic biologyQ862838
P304page(s)9917-9931
P577publication date2016-07-14
P1433published inApplied Microbiology and BiotechnologyQ13553694
P1476titleEnhanced production of nargenicin A1 and creation of a novel derivative using a synthetic biology platform
P478volume100

Reverse relations

cites work (P2860)
Q38406021Actinomadura Species: Laboratory Maintenance and Ribosome Engineering
Q33634190Coalition of Biology and Chemistry for Ameliorating Antimicrobial Drug Discovery
Q61446947Combinatorial approach for improved cyanidin 3-O-glucoside production in Escherichia coli
Q92599386Engineering actinomycetes for biosynthesis of macrolactone polyketides
Q88801399Improved production of 1-deoxynojirymicin in Escherichia coli through metabolic engineering
Q33799744Marine Rare Actinobacteria: Isolation, Characterization, and Strategies for Harnessing Bioactive Compounds.
Q38719554Microbial production of astilbin, a bioactive rhamnosylated flavanonol, from taxifolin.
Q61798192Production of a Novel Tetrahydroxynaphthalene (THN) Derivative from sp. CS682 by Metabolic Engineering and Its Bioactivities
Q50281299Rewriting the Metabolic Blueprint: Advances in Pathway Diversification in Microorganisms
Q38406026Saccharopolyspora Species: Laboratory Maintenance and Enhanced Production of Secondary Metabolites.

Search more.